These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Aksamit TR; Philley JV; Griffith DE Respir Med; 2014 Mar; 108(3):417-25. PubMed ID: 24484653 [TBL] [Abstract][Full Text] [Related]
24. [Non-tuberculous mycobacteriosis. What has been coming out]. Kajiki A Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655 [TBL] [Abstract][Full Text] [Related]
25. Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria. Schweitzer MD; Salamo O; Campos M; Schraufnagel DE; Sadikot R; Mirsaeidi M PLoS One; 2017; 12(9):e0185095. PubMed ID: 28957340 [TBL] [Abstract][Full Text] [Related]
26. Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK. Axson EL; Bual N; Bloom CI; Quint JK Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):117-124. PubMed ID: 30368738 [TBL] [Abstract][Full Text] [Related]
27. Histopathological spectrum of cutaneous tuberculosis and non-tuberculous mycobacterial infections. Min KW; Ko JY; Park CK J Cutan Pathol; 2012 Jun; 39(6):582-95. PubMed ID: 22616600 [TBL] [Abstract][Full Text] [Related]
28. Clinical aspects of the Mycobacterium abscessus complexAuthors' replyClinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian AmazonBurden of non-tuberculous mycobacterial pulmonary disease in GermanyBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Joob B; Wiwanitkit V J Bras Pneumol; 2018; 44(5):434-435. PubMed ID: 30517343 [No Abstract] [Full Text] [Related]
29. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788 [TBL] [Abstract][Full Text] [Related]
30. Epidemiological profile and follow-up of patients with pulmonary disease by non-tuberculous mycobacteria in Baixada Santista area, São Paulo. Coelho AGV; Chiou AC; Pedro HDSP; Nardi SMT; Chimara E Einstein (Sao Paulo); 2022; 20():eAO5510. PubMed ID: 35170707 [TBL] [Abstract][Full Text] [Related]
31. Is NASH underdiagnosed among African Americans? Caldwell SH; Harris DM; Patrie JT; Hespenheide EE Am J Gastroenterol; 2002 Jun; 97(6):1496-500. PubMed ID: 12094872 [TBL] [Abstract][Full Text] [Related]
32. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort. Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034 [TBL] [Abstract][Full Text] [Related]
33. Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population. Prevots DR; Adjemian J; Fernandez AG; Knowles MR; Olivier KN Ann Am Thorac Soc; 2014 Sep; 11(7):1032-8. PubMed ID: 25068620 [TBL] [Abstract][Full Text] [Related]
34. 'Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis. Ku JH; Ranches G; Siegel SAR; Winthrop KL Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114916. PubMed ID: 31740173 [TBL] [Abstract][Full Text] [Related]
35. Deaths Related to Nontuberculous Mycobacterial Infections in the United States, 1999-2014. Vinnard C; Longworth S; Mezochow A; Patrawalla A; Kreiswirth BN; Hamilton K Ann Am Thorac Soc; 2016 Nov; 13(11):1951-1955. PubMed ID: 27607541 [TBL] [Abstract][Full Text] [Related]
36. Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016. Zhang ZX; Cherng BPZ; Sng LH; Tan YE BMC Infect Dis; 2019 May; 19(1):436. PubMed ID: 31101082 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology, demographics, and genetics of sarcoidosis. Rybicki BA; Maliarik MJ; Major M; Popovich J; Iannuzzi MC Semin Respir Infect; 1998 Sep; 13(3):166-73. PubMed ID: 9764947 [TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis. Vande Weygaerde Y; Cardinaels N; Bomans P; Chin T; Boelens J; André E; Van Braeckel E; Lorent N BMC Infect Dis; 2019 Dec; 19(1):1061. PubMed ID: 31847834 [TBL] [Abstract][Full Text] [Related]
39. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614 [TBL] [Abstract][Full Text] [Related]